Most people who get a herpes diagnosis ask the same question first: if I stay with my partner, what are the odds I pass it to them? The fear usually runs ahead of the data. The actual numbers are knowable, they come from good studies, and they are lower than the panic suggests. This post lays out the per-year transmission rate for genital HSV-2 and then shows what each protective layer adds on top of that baseline.

The baseline rate in a discordant couple

A discordant couple is one where one partner has genital HSV-2 and the other does not. The best transmission data come from the placebo arm of a large randomized trial. In that trial, 1,484 heterosexual monogamous couples were followed for eight months. In the couples taking no antiviral, the susceptible partner acquired symptomatic HSV-2 in 3.6 percent of couples over those eight months (Corey et al., NEJM 2004).

Scaled to a year, that is roughly a 4 to 5 percent annual risk with no precautions of any kind, in a couple having regular unprotected sex. That figure already folds in the reality that the positive partner is shedding virus on days they feel nothing.

Two things shift the baseline before you add any intervention.

Direction of transmission. Male-to-female transmission runs higher than female-to-male. Female partners in the trial acquired the virus more often than male partners, which tracks with the larger mucosal surface exposed during receptive sex.

Prior HSV-1. If the susceptible partner already carries oral HSV-1 from childhood, their risk of acquiring HSV-2 is partially reduced. Existing antibodies blunt the new infection. This is not full protection, but it lowers the starting number.

So the honest baseline is a single-digit annual percentage, varying by direction and by the susceptible partner's existing antibody status.

What daily suppression adds

In the same trial, the partner with HSV-2 took valacyclovir 500 mg once daily. Acquisition in the susceptible partner dropped from 3.6 percent to 1.9 percent over eight months, a hazard ratio of 0.52 (Corey et al., NEJM 2004). That is close to a halving of risk.

The mechanism is asymptomatic shedding. Most HSV-2 transmission happens on days the positive partner has no sore and no symptom, while virus is quietly present on the skin. Daily antiviral cuts how often that shedding occurs, which is why suppression lowers transmission even though it does nothing about a visible outbreak you would already avoid sex during.

Suppression cuts the rate by about half. It does not get you to zero. If you are weighing whether to take a daily pill for this, the daily versus episodic comparison walks through who each approach fits.

What condoms add

Condoms reduce HSV-2 transmission, with an important asymmetry. In a pooled analysis of prospective data, consistent condom use was associated with roughly a 30 percent reduction in HSV-2 acquisition across both sexes (Martin et al., Arch Intern Med 2009). Earlier work found the protection was stronger for women than for men, because condoms cover the male anatomy that sheds virus but leave female partners more exposed to skin the condom does not cover (Wald et al., 2001).

The 30 percent figure is real and worth having. It is also a reminder that condoms underperform here compared to how they perform against fluid-borne infections like HIV. Herpes spreads from skin a condom does not cover. That gap is the whole reason condoms help less than people assume.

What disclosure and timing add

Disclosure is not a pharmacologic intervention, but it changes behavior in ways that lower risk. A partner who knows can avoid sex during the prodrome (the tingling or itching that precedes an outbreak) and during a visible sore, which are the highest-shedding windows. Avoiding sex during symptomatic periods removes the days when transmission risk spikes well above the asymptomatic baseline.

Disclosure also lets the couple choose the other layers deliberately rather than by accident, and how to have that conversation is its own skill. There is no clean percentage to attach to disclosure alone, because its effect runs entirely through the behavior it enables. But avoiding contact during active and prodromal periods is one of the few things that addresses the high-risk days directly.

Stacking the layers

These interventions are not redundant. They work on different parts of the problem, so they multiply rather than overlap.

  • Suppression cuts asymptomatic shedding, which drives most transmission.
  • Condoms block contact with covered skin.
  • Avoiding sex during outbreaks and prodrome removes the highest-risk days.

A couple using all three pushes the annual risk well below the single-digit baseline. The Corey trial itself combined suppression with counseling on condom use and abstaining during outbreaks, and even the layered approach did not reach zero (Corey et al., NEJM 2004). The honest message is that the risk becomes small, not absent, and that many discordant couples live for years without transmission.

Putting a real number on it

Here is a fair summary for a heterosexual discordant couple having regular sex:

  • No precautions: roughly 4 to 5 percent per year, higher male-to-female, lower if the susceptible partner has prior HSV-1.
  • Add daily suppression: cut that roughly in half.
  • Add consistent condoms: shave off another portion, more protective for a female susceptible partner.
  • Add avoiding sex during prodrome and outbreaks: removes the spike days.

Stacked, a couple is looking at a low single-digit or sub-one-percent annual risk depending on the combination and the direction. That is a number people can plan a relationship around, which is the point of having it.

The bottom line

The baseline transmission risk in a discordant couple is a few percent a year, not the near-certainty people imagine. Suppression roughly halves it. Condoms add a modest further cut. Avoiding sex during symptoms removes the worst days. None of the layers alone gets you to zero, and stacked they get you close. Knowing the real numbers lets a couple make a decision instead of carrying a fear that the data do not support.

Medically reviewed by: [Reviewer name, credentials] — [Date]

If you want to lower transmission risk to a partner, a licensed clinician can review your history and set up daily suppressive therapy. Start an online visit.

This article is for general education and is not a substitute for personalized medical advice from a licensed clinician.